Physician profile
Miranda Wiggins
NPI 1679847776
$634.55
in general payments reported to CMS, 2019-2025
11 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.03 · 2022: $42.77 · 2023: $351 · 2024: $84.68 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.75 |
| Education | $102.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $252.05 | 2022-2025 | Verquvo |
| Medtronic, INC. | $81.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.83 | 2023 | Lifevest |
| Philips North America LLC | $48.47 | 2023-2024 | (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $35.38 | 2023-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.85 | 2025 | Jardiance |
| Cvrx, INC. | $29.13 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $26.28 | 2023 | Camzyos |
| Pfizer INC. | $24.53 | 2025 | |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
| Genentech USA, INC. | $18.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Wiggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.